Abstract
Over the past 3 decades, controlled studies have demonstrated the efficacy of psychotropic medications for most psychiatric disorders. Still for many patients and their families, the outcome is disappointing. A critical issue is how to increase the effectiveness of “effective” medication. In no other disorder is the challenge greater than in combining psychosocial interventions to improve neuroleptic treatment outcome for schizophrenia.
Parts of this chapter are adapted from a study group, “Maximizing the Effectiveness of Medication for Schizophrenia and Affective Disorder.” Presented at the 1991 ACNP Meeting in San Juan, and published in Psychopharmacol Bull 28:223–225 (1992)
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bellack AS, Mueser KT (1993) Psychosocial treatment for schizophrenia. Schizophr Bull 18:317–336.
Corrigan PW, Liberman RP, Engel JD (1990) From noncompliance to collaboration in the treatment of schizophrenia. Hosp Commun Psychiatry 41:1203–1211.
Clarkin JF, Glick ID, Haas GL, Spencer JH, Lewis, AB, Peyser JA, DeMane N, Good-Ellis M, Harris E, Lestelle V (1990) A randomized clinical trial of inpatient family intervention. V. Results for affective disorders. J Affect Disord 18:17–28.
Glick ID, Clarkin JF, Haas GL et al. (1991a) A randomized clinical trial of inpatient family intervention. VI. Mediating variables and outcome. Family Process 30:85–91.
Glick ID, Burti L, Suzuki K, Sacks M (1991b) Effectiveness in psychiatric care. I. A cross-national study of the process of treatment and outcomes of major depressive disorder. J Nerv Ment Dis 179:55–63.
Glick ID, Hargreaves WA (1979) Psychiatric hospital treatment for the 1980s: a controlled study of short versus long hospitalization. Lexington Press, Lexington Mass.
Glick ID, Jacobs M, Lieberman J, Simpson G, Schooler NR, and the Treatment Strategies in Schizophrenia Collaborative Study Group (1989) Prediction of short term outcome in schizophrenia: depressive symptoms, negative symptoms, and extrapyramidal signs. Psychopharmacol Bull 25:344–347.
Glick ID, Spencer JH, Clarkin JF, Haas GL, Lewis AB, Peyser J, DeMane N, Good-Ellis M, Harris E, Lestelle V (1990) A randomized clinical trial of inpatient family intervention IV. Followup results for subjects with schizophrenia. Schizophr Res 3:187–200.
Hirsch S, Bowen J, Emami J, Cramer P, Jolley A, Haw C, Dickinson M (1994) A one year prospective study of the effect of life events and medication in the aetiology of schizophrenic relapse. Arch Gen Psychiatry (in press).
Keith SJ, Bellack A, Frances A, Mance R, Matthews S, and the Treatment Strategies in Schizophrenia Collaborative Study Group (1989) The influence of diagnosis and family treatment on acute treatment response and short term outcome in schizophrenia. Psychopharmacol Bull, 25:336–339.
Schooler NR, Keith SJ, Severe JB, Matthews S (1989) Acute treatment response and short term outcome in schizophrenia: first results of the NIMH Treatment Strategies in Schizophrenia study. Psychopharmacol Bull 25:331–335.
Spencer JH, Glick ID, Haas GL (1988) A randomized clinical trial of inpatient family intervention III. Overall effects at followup for the entire sample. Am J Psychiatry 145:1115–1121.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag Wien
About this paper
Cite this paper
Glick, I.D. (1994). Neuroleptic-psychosocial interactions and prediction of outcome. In: Gaebel, W., Awad, A.G. (eds) Prediction of Neuroleptic Treatment Outcome in Schizophrenia. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6636-9_7
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6636-9_7
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-82602-7
Online ISBN: 978-3-7091-6636-9
eBook Packages: Springer Book Archive